These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30552787)

  • 1. Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels.
    Plomgaard P; Hansen JS; Ingerslev B; Clemmesen JO; Secher NH; van Hall G; Fritsche A; Weigert C; Lehmann R; Häring HU; Heni M
    Diabetes Obes Metab; 2019 Apr; 21(4):993-1000. PubMed ID: 30552787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men.
    Heni M; Wagner R; Kullmann S; Gancheva S; Roden M; Peter A; Stefan N; Preissl H; Häring HU; Fritsche A
    Diabetes; 2017 Jul; 66(7):1797-1806. PubMed ID: 28174292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations.
    Dash S; Xiao C; Morgantini C; Koulajian K; Lewis GF
    Diabetes; 2015 Mar; 64(3):766-74. PubMed ID: 25288674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intranasal insulin on endogenous glucose production in insulin-resistant men.
    Xiao C; Dash S; Stahel P; Lewis GF
    Diabetes Obes Metab; 2018 Jul; 20(7):1751-1754. PubMed ID: 29536605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men.
    Xiao C; Dash S; Stahel P; Lewis GF
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
    Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
    Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Igawa K; Chu CA; Balcom JH; Neal DW; Cherrington AD
    Am J Physiol; 1999 Apr; 276(4):E806-13. PubMed ID: 10198319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity.
    Kullmann S; Veit R; Peter A; Pohmann R; Scheffler K; Häring HU; Fritsche A; Preissl H; Heni M
    J Clin Endocrinol Metab; 2018 Jan; 103(1):253-262. PubMed ID: 29095982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
    Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes.
    Mudaliar S; Henry RR; Ciaraldi TP; Armstrong DA; Burke PM; Pettus JH; Garhyan P; Choi SL; Knadler MP; Lam EC; Prince MJ; Bose N; Porksen NK; Sinha VP; Linnebjerg H; Jacober SJ
    Diabetes Obes Metab; 2016 Oct; 18 Suppl 2():17-24. PubMed ID: 27723226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus.
    Kashiwagi A
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S195-200. PubMed ID: 8529514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
    Wise S; Nielsen M; Rizza R
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans.
    Gancheva S; Koliaki C; Bierwagen A; Nowotny P; Heni M; Fritsche A; Häring HU; Szendroedi J; Roden M
    Diabetes; 2015 Jun; 64(6):1966-75. PubMed ID: 25576060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism.
    Raboudi N; Arem R; Jones RH; Chap Z; Pena J; Chou J; Field JB
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E159-66. PubMed ID: 2643338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.
    Heni M; Wagner R; Kullmann S; Veit R; Mat Husin H; Linder K; Benkendorff C; Peter A; Stefan N; Häring HU; Preissl H; Fritsche A
    Diabetes; 2014 Dec; 63(12):4083-8. PubMed ID: 25028522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.
    Alkhalidy H; Moore W; Wang A; Luo J; McMillan RP; Wang Y; Zhen W; Hulver MW; Liu D
    J Nutr Biochem; 2018 Aug; 58():90-101. PubMed ID: 29886193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.
    Gregory JM; Rivera N; Kraft G; Winnick JJ; Farmer B; Allen EJ; Donahue EP; Smith MS; Edgerton DS; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E273-E283. PubMed ID: 28512154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects.
    Henry RR; Mudaliar S; Ciaraldi TP; Armstrong DA; Burke P; Pettus J; Garhyan P; Choi SL; Jacober SJ; Knadler MP; Lam EC; Prince MJ; Bose N; Porksen N; Sinha VP; Linnebjerg H
    Diabetes Care; 2014 Sep; 37(9):2609-15. PubMed ID: 24947791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.